T1	Premise 905 1025	Significant differences in QoL emerged in activity limitation, physical capacity, and sexual functioning, favouring IAD.
T2	Premise 1026 1319	No significant differences emerged in the prevalence of AEs: 87 patients in the IAD arm (31.8%) and 95 in the CAD arm (33.9%) had cardiovascular (CV) AEs (p=0.59), with 25 (9.1%) and 29 (10.4%) withdrawn (p=0.62), and 21 (7.7%) and 24 (8.6%) dying because of a CV event (p=0.70), respectively;
T3	Premise 1320 1403	bone fractures occurred in 19 (6.9%) and 15 (5.4%) patients (p=0.44), respectively.
T4	Premise 1404 1483	Hot flushes or night sweats were the most common ADRs (47.1% vs 50.4%; p=0.44).
T5	Premise 1484 1602	Erectile dysfunction (15.7% vs 7.9%; p=0.042) and depressed mood (2.2 vs 0%; p=0.032) were more common in the IAD arm.
T6	Claim 1603 1676	IAD showed benefits in the treatment of advanced PCa with respect to QoL.
T7	Claim 1677 1736	The prevalence of AEs was not significantly lower with IAD.
R1	Support Arg1:T5 Arg2:T7	
R2	Support Arg1:T4 Arg2:T7	
R3	Support Arg1:T2 Arg2:T7	
R4	Support Arg1:T3 Arg2:T7	
R5	Support Arg1:T1 Arg2:T6	
